Reuters logo
BRIEF-Active Biotech Q4 operating loss narrows to SEK 13.5 mln
February 16, 2017 / 7:40 AM / 8 months ago

BRIEF-Active Biotech Q4 operating loss narrows to SEK 13.5 mln

Feb 16 (Reuters) - Active Biotech Ab:

* Q4 net sales SEK 7.1 million versus SEK 5.0 million year ago

* Q4 operating loss SEK 13.5 million versus SEK 28.2 million year ago

* Says operations are progressing according to plan pending the Phase 3 results for laquinimod in the first half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below